Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1087
Source ID: NCT02827435
Associated Drug: Rocuronium Bromide
Title: Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft
Acronym:
Status: RECRUITING
Study Results: NO
Results:
Conditions: End Stage Renal Disease|Transplantation
Interventions: DRUG: Rocuronium bromide
Outcome Measures: Primary: rocuronium plasma concentration (mcg/ml), PKPD modeling from measuring plasma rocuronium concentration and excreted urine rocuronium amount, 0, 1, 3, 5, 10, 30, 60, 90, 120 minutes after rocuronium second bolus injection|acceleromyography data (TOF ratio %), Muscle relaxation level (TOF, T1) will be evaluated via acceleromyography. The pharmacodynamic modeling with NONMEM throughout the kidney transplantation., intraoperative |
Sponsor/Collaborators: Sponsor: Seoul National University Hospital
Gender: ALL
Age: ADULT
Phases:
Enrollment: 12
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Start Date: 2016-07-01
Completion Date: 2024-12-31
Results First Posted:
Last Update Posted: 2023-12-01
Locations: Seoul National University Hospital, Seoul, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT02827435